Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
- DOI
- 10.3310/hta23260
- Published
- 2019 May
- Container
- Health technology assessment (Winchester, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3310/hta23260,
title = {Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.},
author = {Webb NJ and Woolley RL and Lambe T and Frew E and Brettell EA and Barsoum EN and Trompeter RS and Cummins C and Wheatley K and Ives NJ},
year = {2019},
journal = {Health technology assessment (Winchester, England)},
doi = {10.3310/hta23260},
url = {https://doi.org/10.3310/hta23260}
}RIS
TY - JOUR TI - Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. AU - Webb NJ AU - Woolley RL AU - Lambe T AU - Frew E AU - Brettell EA AU - Barsoum EN AU - Trompeter RS AU - Cummins C AU - Wheatley K AU - Ives NJ PY - 2019 JO - Health technology assessment (Winchester, England) DO - 10.3310/hta23260 UR - https://doi.org/10.3310/hta23260 ER -
APA
NJ, W., RL, W., T, L., E, F., EA, B., EN, B., RS, T., C, C., K, W., & NJ, I. (2019). Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.. Health technology assessment (Winchester, England). https://doi.org/10.3310/hta23260
Source records
- pubmed · retrieved 2026-09-25T05:38:43.776Z